This document discusses the importance of accurate cell counting methods throughout the development and manufacturing of chimeric antigen receptor (CAR) T-cell therapy. It outlines how cell counters can provide consistency, accuracy, and efficiency from research and development through manufacturing. The document emphasizes that accurate cell counting is critical at various stages, including optimizing viral vector development, determining transduction efficiencies, and ensuring proper cell numbers for downstream applications. It also notes that establishing robust cell counting procedures early in the development process is crucial for parameters like safety, purity, identity, potency, and stability.